Cooperativity between the polyamine pathway and HER-2neu in transformation of human mammary epithelial cells in culture: Role of the MAPK pathway

International Journal of Cancer

Volumn 76, Issue 4, 1998, Pages 563-570

  Manni, Andrea ^a   Wechter, Rita ^a   Verderame, Michael F ^a   Mauger, David ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; NEU DIFFERENTIATION FACTOR; ORNITHINE DECARBOXYLASE; POLYAMINE;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CANCER PREVENTION; CELL LINE; CELL TRANSFORMATION; CONTROLLED STUDY; DRUG TARGETING; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; ONCOGENE NEU; POLYAMINE SYNTHESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

BREAST; BREAST NEOPLASMS; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; CLONE CELLS; ENZYME ACTIVATION; EPITHELIUM; HUMANS; MAP KINASE KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; ORNITHINE DECARBOXYLASE; POLYAMINES; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; SIGNAL TRANSDUCTION;

EID: 0031981867     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980518)76:4<563::AID-IJC20>3.0.CO;2-7     Document Type: Article

References (29)

1. ALHONEN, L. HALMEKYTO, M., KOSMA, V.-M., WAHLFORS, J., KAUPPINEN, R. and JANNE, J., Life-long over-expression of ornithine decarboxylase (ODC) gene in transgenic mice does not lead to generally enhanced tumorigenesis or neuronal degeneration. Int. J. Cancer. 63, 402-404 (1995).
2. BACUS, S.S., KIGUCHI, K., CHIN, D., KING, R. and HUBERMAN, E., Differentiation of cultured human breast cancer cells (AU-565) and MCF-7) associated with loss of cell surface HER-2/neu antigen. Mol. Carcinogenesis, 3, 350-362 (1990).
3. CLIFFORD, A., MORGAN, D., YUSPA, S.H., SOLER, A.P. and GILMOUR, S., Role of ornithine decarboxylase in epidermal tumorigenesis. Cancer Res., 55, 1680-1686 (1995).
4. GILMOUR, S.K., VERMA, A.K., MADARA, T. and O'BRIEN, T.G., Regulation of ornithine decarboxylase gene expression in mouse epidermis and epidermal tumors during two-stage tumorigenesis. Cancer Res., 47, 1221-1225 (1987).
5. JANES, P.W., DALY, R.J., DEFAZIO, A. and SUTHERLAND, R.L., Activation of the ras signalling pathway in human breast cancer cells overexpressing erbB-2. Oncogene, 9, 3601-3608 (1994).
6. JOHNSON, G.L., Editorial: Signal transduction abnormalities in cancer mitogen-activated protein kinase regulation is altered in breast cancer. J. clin. Invest., 99, 1463-1464 (1997).
7. KARUNAGARAN, D., TZAHAR, E., BEERLI, R.R., CHEN, X., GRAUS-PORTA, D., RATZKIN, B.J., SEGER, R., HYNES, N.E. and YARDEN, Y., ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer. EMBO J., 15, 254-264 (1996).
8. KUBOTA, S., KIYOSAWA, H., NOMURA, Y., YAMADA, T. and SEYAMA, Y., Ornithine decarboxylase overexpression in mouse 10T1/2 fibroblasts: cellular transformation and invasion. J. nat. Cancer Inst., 89, 567-571 (1997).
9. LUK, G.D. and BAYLIN, S.B., Ornithine decarboxylase as a biological marker in familial colonic polyposis. N. Engl. J. Med., 311, 80-83 (1984).
10. MANM, A. The role of the polyamine pathway in breast cancer development, progression and proliferation. A possible target for antitumor therapy. Endocrine-Related Cancer, 2, 141-151 (1995).
11. MANNI, A., GROVE, R., KUNSELMAN, S. and ALDAZ, M., Involvement of the polyamine pathway in breast cancer progression. Cancer Lett., 92, 49-57 (1995).
12. MANNI, A., MAUGER, D., GIMOTTY, P. and BADGER, B., Prognostic influence on survival of increased ornithine decarboxylase activity in human breast cancer. Clin. Cancer Res., 2, 1901-1906 (1996).
13. MANNI, A., WECHTER, R., GILMOUR, S., VERDERAME, M.F., MAUGER, D. and DEMERS. L.M., Ornithine decarboxylase over-expression stimulates mitogen-activated protein kinase and anchorage-independent growth of human breast epithelial cells. Int. J. Cancer. 70, 175-182 (1997).
14. MARSHALL, C.J., Specificity of receptor tyrosine kinase signaling: Transient vs. sustained extracellular signal-regulated kinase activation. Cell, 80, 179-185 (1995).
15. MOSHIER, J.A., DOSESCU, J., SKUNCA, M. and LUK, G.D., Transformation of NIH/3T3 cells by ornithine decarboxylase overexpression. Cancer Res., 53, 2618-2622 (1993).
16. O'BRIEN, T.G. The induction of ornithine decarboxylase as an early, possibly obligatory, event in mouse skin carcinogenesis. Cancer Res., 36, 2644-2653 (1976).
17. PACKMAN, G. und CLEVELAND, J.L., Ornithine decarboxylase is a mediator of c-Myc-induced apoptosis. Mol. cell. Biol., 14, 5741-5747 (1994).
18. PEGG, A.E. Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy. Cancer Res., 48, 759-774 (1988).
19. 1-acetylspermidine in human breast cancer. Cancer Lett., 45, 83-86 (1989).
20. RAM, T.G., KOKENY, K.E., DILTS, C.A. and ETHIER, S.P., Mitogenic activity of neu differentiation factor/heregulin mimics that of epidermal growth factor and insulin-like growth factor-1 in human mammary epithelial cells. J. cell. Physiol., 163, 589-596 (1995).
21. SCALABRINO, G. and FERIOLI, M.E., Polyamines in mammalian tumors: part I. Adv. Cancer Res., 35, 151-268 (1981).
22. SCALABRINO, G. and FFRIOLI, M.E., Polyamines in mammalian tumors: part II. Adv. Cancer Res., 36, 1-102 (1982).
23. SCHEDIN, P.J., STRANGE, R., SINGH, M., KAECK, M.R., FONTAINE, S.C. and THOMPSON, H.J., Treatment with chemopreventive agents, difluoromethylornithine and retinyl acetate, results in altered mammary extracellular matrix. Carcinogenesis, 16, 1787-1744 (1995).
24. SIMON, C., JUAREZ, J., NICOLSON, G.L. and BOYD, D., Effect of PD 098059, a specific inhibitor of mitogen-activated protein kinase kinase, on urokinase expression and in vitro invasion. Cancer Res., 56, 5369-5374 (1996).
25. SIVARAMAN, V.S., WANG, H.-Y., NUOVO, G.J. and MALBON, C.C., Hyperexpression of milogen-activated protein kinase in human breast cancer. J. clin. Invest., 99, 1478-1483 (1997).
26. SLAMON, D.J., GODOLPHIN, W., JONES, L.A., HOLT, J.A., WONG, S.G., KEITH, D.E., LEVIN, W.J., STUART, S.G., UDOVE, J., ULLRICH, A. and PRESS, M.F., Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science, 244, 707-712 (1989).
27. SOULE, H., MALONEY, T.M., WOLMAN, S.R., PETERSON, JR., W.D., BRENZ, R., MCGRATH, C.M., RUSSO, J., PAULEY, R.J., JONES, R.F. and BROOKS, S.C., Isolation and characterization of a spontaneously immortalized human breast epithelial cell line MCT-10. Cancer Res., 50, 6075-6086 (1990).
28. TOME, M.E., FISER, S.M. and GERNER, B.W., Consequences of aberrant ornithine decarhoxylase regulation in rat hepatoma cells. J. cell. Physiol. 158, 237-244 (1994).
29. XIA. Z., DICKENS, M., RAINGEAUD, J., DAVIS, R.J. and GREENBERG,. M.E., Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science, 270, 1326-1331 (1995).